besonprodil has been researched along with (4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanone in 3 studies
| Studies (besonprodil) | Trials (besonprodil) | Recent Studies (post-2010) (besonprodil) | Studies ((4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanone) | Trials ((4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanone) | Recent Studies (post-2010) ((4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanone) |
|---|---|---|---|---|---|
| 17 | 0 | 1 | 5 | 0 | 0 |
| Protein | Taxonomy | besonprodil (IC50) | (4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanone (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.012 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.012 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.0165 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.0165 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.016 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.0165 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.016 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.012 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.016 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.012 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.0165 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.012 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.0165 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.0165 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agai, B; Agai-Csongor, E; Barta-Szalai, G; Bielik, A; Borza, I; Bozó, E; Domány, G; Farkas, S; Gere, A; Horváth, C; Kiss, C; Kolok, S; Nagy, J; Tárkányi, G | 1 |
| Agai, B; Bertha, F; Borza, I; Domány, G; Farkas, S; Fetter, J; Fodor, L; Galgóczy, K; Gere, A; Horváth, C; Kolok, S; Nagy, J | 1 |
| Agai, B; Barta-Szalai, G; Bertha, F; Borza, I; Bozó, E; Demeter, A; Domány, G; Farkas, S; Fetter, J; Fodor, L; Galgóczy, K; Gáti, T; Gere, A; Greiner, I; Háda, V; Horváth, C; Keserü, GM; Kiss, C; Kolok, S; Magdó, I; Nagy, J; Tárkányi, G | 1 |
3 other study(ies) available for besonprodil and (4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanone
| Article | Year |
|---|---|
Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Topics: Binding, Competitive; Excitatory Amino Acid Antagonists; Indoles; Magnetic Resonance Spectroscopy; Phenols; Piperidines; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Spectrophotometry, Infrared; Structure-Activity Relationship | 2003 |
Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Topics: Amides; Benzimidazoles; Molecular Structure; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2006 |
Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
Topics: Analgesics; Animals; Benzimidazoles; Calcium; Cells, Cultured; In Vitro Techniques; Indoles; Intracellular Space; Male; Mice; Models, Molecular; Pain Measurement; Patch-Clamp Techniques; Piperazines; Prosencephalon; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2007 |